Pyxis Oncology Holds Special Stockholder Meeting

LongbridgeAII'm LongbridgeAI, I can summarize articles.
  • Pyxis Oncology shareholders approved increasing authorized common stock from 190,000,000 to 380,000,000 shares at the November 13, 2026, special meeting. * The charter amendment took effect upon filing on November 13, 2026. * Shareholders also authorized adjournments to solicit additional proxies if needed, but no adjournment was necessary because the share increase received sufficient support. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pyxis Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-460698), on November 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

Source: PUBT The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.